Detailed information for compound 1726727

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 343.382 | Formula: C20H17N5O
  • H donors: 1 H acceptors: 4 LogP: 3.1 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(Nc1nc(C)nc2c1nn(c2)c1ccccc1)Cc1ccccc1
  • InChi: 1S/C20H17N5O/c1-14-21-17-13-25(16-10-6-3-7-11-16)24-19(17)20(22-14)23-18(26)12-15-8-4-2-5-9-15/h2-11,13H,12H2,1H3,(H,21,22,23,26)
  • InChiKey: CFJGGVBAABFYDB-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens adenosine A3 receptor Starlite/ChEMBL References
Homo sapiens adenosine A1 receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi hypothetical protein adenosine A1 receptor 326 aa 305 aa 21.0 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Leishmania major dihydrofolate reductase-thymidylate synthase 0.0342 0.6968 1
Mycobacterium ulcerans hypothetical protein 0.0159 0.1565 0.1565
Trypanosoma brucei mitochondrial DNA polymerase beta 0.0301 0.5762 0.7949
Mycobacterium tuberculosis Conserved hypothetical protein 0.0159 0.1565 0.1565
Leishmania major mitochondrial DNA polymerase beta 0.0301 0.5762 0.7949
Plasmodium vivax bifunctional dihydrofolate reductase-thymidylate synthase, putative 0.0342 0.6968 0.5
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase 0.0342 0.6968 0.5
Toxoplasma gondii bifunctional dihydrofolate reductase-thymidylate synthase 0.0342 0.6968 0.5
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0301 0.5762 0.7949
Trypanosoma cruzi mitochondrial DNA polymerase beta, putative 0.0301 0.5762 0.7949
Trypanosoma brucei dihydrofolate reductase-thymidylate synthase 0.0342 0.6968 1
Trypanosoma cruzi dihydrofolate reductase-thymidylate synthase 0.0342 0.6968 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 1 % Inhibition of human A2B adenosine receptor transfected in CHO cells assessed as inhibition of NECA-induced cyclic AMP production at 1 uM after 10 mins by competitive protein binding assay ChEMBL. 23427825
Inhibition (binding) = 13 % Displacement of [3H]ZM241385 from human A2A adenosine receptor expressed in CHO cells at 1 uM after 60 mins by scintillation counting analysis ChEMBL. 23427825
Ki (binding) = 120 nM Displacement of [125I]AB-MECA from human A3 adenosine receptor expressed in CHO cells after 60 mins by scintillation counting analysis ChEMBL. 23427825
Ki (binding) = 510 nM Displacement of [3H]DPCPX from human A1 adenosine receptor expressed in CHO cells after 120 mins by scintillation counting analysis ChEMBL. 23427825

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.